285 related articles for article (PubMed ID: 9182685)
1. In vivo detection of dendritic cell antigen presentation to CD4(+) T cells.
Ingulli E; Mondino A; Khoruts A; Jenkins MK
J Exp Med; 1997 Jun; 185(12):2133-41. PubMed ID: 9182685
[TBL] [Abstract][Full Text] [Related]
2. Killing of naive T cells by CD95L-transfected dendritic cells (DC): in vivo study using killer DC-DC hybrids and CD4(+) T cells from DO11.10 mice.
Kusuhara M; Matsue K; Edelbaum D; Loftus J; Takashima A; Matsue H
Eur J Immunol; 2002 Apr; 32(4):1035-43. PubMed ID: 11920570
[TBL] [Abstract][Full Text] [Related]
3. The role of antigen-presenting cells and interleukin-12 in the priming of antigen-specific CD4+ T cells by immune stimulating complexes.
Robson NC; Beacock-Sharp H; Donachie AM; Mowat AM
Immunology; 2003 Sep; 110(1):95-104. PubMed ID: 12941146
[TBL] [Abstract][Full Text] [Related]
4. Anatomic location defines antigen presentation by dendritic cells to T cells in response to intravenous soluble antigens.
Chung Y; Chang JH; Kim BS; Lee JM; Kim HY; Kang CY
Eur J Immunol; 2007 Jun; 37(6):1453-62. PubMed ID: 17474148
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes.
Porgador A; Gilboa E
J Exp Med; 1995 Jul; 182(1):255-60. PubMed ID: 7540653
[TBL] [Abstract][Full Text] [Related]
6. Revealing the in vivo behavior of CD4+ T cells specific for an antigen expressed in Escherichia coli.
Chen ZM; Jenkins MK
J Immunol; 1998 Apr; 160(7):3462-70. PubMed ID: 9531307
[TBL] [Abstract][Full Text] [Related]
7. In situ analysis reveals physical interactions between CD11b+ dendritic cells and antigen-specific CD4 T cells after subcutaneous injection of antigen.
Ingulli E; Ulman DR; Lucido MM; Jenkins MK
J Immunol; 2002 Sep; 169(5):2247-52. PubMed ID: 12193689
[TBL] [Abstract][Full Text] [Related]
8. Restricted aeroallergen access to airway mucosal dendritic cells in vivo limits allergen-specific CD4+ T cell proliferation during the induction of inhalation tolerance.
Fear VS; Burchell JT; Lai SP; Wikstrom ME; Blank F; von Garnier C; Turner DJ; Sly PD; Holt PG; Strickland DS; Stumbles PA
J Immunol; 2011 Nov; 187(9):4561-70. PubMed ID: 21930961
[TBL] [Abstract][Full Text] [Related]
9. Modulation of naive CD4+ T-cell responses to an airway antigen during pulmonary mycobacterial infection.
Anis MM; Fulton SA; Reba SM; Harding CV; Boom WH
Infect Immun; 2007 May; 75(5):2260-8. PubMed ID: 17296758
[TBL] [Abstract][Full Text] [Related]
10. CD4(+) T cell-released exosomes inhibit CD8(+) cytotoxic T-lymphocyte responses and antitumor immunity.
Zhang H; Xie Y; Li W; Chibbar R; Xiong S; Xiang J
Cell Mol Immunol; 2011 Jan; 8(1):23-30. PubMed ID: 21200381
[TBL] [Abstract][Full Text] [Related]
11. Influence of mucosal adjuvants on antigen passage and CD4+ T cell activation during the primary response to airborne allergen.
Wikstrom ME; Batanero E; Smith M; Thomas JA; von Garnier C; Holt PG; Stumbles PA
J Immunol; 2006 Jul; 177(2):913-24. PubMed ID: 16818746
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-10-treated dendritic cells do not inhibit Th2 immune responses in ovalbumin/alum-sensitized mice.
Bellinghausen I; Sudowe S; König B; Reske-Kunz AB; Knop J; Saloga J
Int Arch Allergy Immunol; 2006; 141(1):61-9. PubMed ID: 16804328
[TBL] [Abstract][Full Text] [Related]
13. Microparticulate β-glucan vaccine conjugates phagocytized by dendritic cells activate both naïve CD4 and CD8 T cells in vitro.
Berner VK; duPre SA; Redelman D; Hunter KW
Cell Immunol; 2015; 298(1-2):104-14. PubMed ID: 26549577
[TBL] [Abstract][Full Text] [Related]
14. Rational design of nanoparticles towards targeting antigen-presenting cells and improved T cell priming.
Zupančič E; Curato C; Paisana M; Rodrigues C; Porat Z; Viana AS; Afonso CAM; Pinto J; Gaspar R; Moreira JN; Satchi-Fainaro R; Jung S; Florindo HF
J Control Release; 2017 Jul; 258():182-195. PubMed ID: 28511928
[TBL] [Abstract][Full Text] [Related]
15. UVB-irradiated dendritic cells are impaired in their APC function and tolerize primed Th1 cells but not naive CD4+ T cells.
Denfeld RW; Hara H; Tesmann JP; Martin S; Simon JC
J Leukoc Biol; 2001 Apr; 69(4):548-54. PubMed ID: 11310840
[TBL] [Abstract][Full Text] [Related]
16. Activation of invariant natural killer T cells in regional lymph nodes as new antigen-specific immunotherapy via induction of interleukin-21 and interferon-γ.
Sakurai T; Inamine A; Iinuma T; Funakoshi U; Yonekura S; Sakurai D; Hanazawa T; Nakayama T; Ishii Y; Okamoto Y
Clin Exp Immunol; 2014 Oct; 178(1):65-74. PubMed ID: 24943738
[TBL] [Abstract][Full Text] [Related]
17. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance.
Bonifaz L; Bonnyay D; Mahnke K; Rivera M; Nussenzweig MC; Steinman RM
J Exp Med; 2002 Dec; 196(12):1627-38. PubMed ID: 12486105
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of dendritic cells and anti-CD3/CD28 expanded regulatory T cells for application in transplantation.
Zeng M; Guinet E; Nouri-Shirazi M
Transpl Immunol; 2009 Dec; 22(1-2):82-92. PubMed ID: 19635560
[TBL] [Abstract][Full Text] [Related]
19. The effects of TCDD on the activation of ovalbumin (OVA)-specific DO11.10 transgenic CD4(+) T cells in adoptively transferred mice.
Shepherd DM; Dearstyne EA; Kerkvliet NI
Toxicol Sci; 2000 Aug; 56(2):340-50. PubMed ID: 10910992
[TBL] [Abstract][Full Text] [Related]
20. Presentation of the self antigen myelin basic protein by dendritic cells leads to experimental autoimmune encephalomyelitis.
Dittel BN; Visintin I; Merchant RM; Janeway CA
J Immunol; 1999 Jul; 163(1):32-9. PubMed ID: 10384096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
